Works by Porter, John B.

Results: 67

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias.

Published in:

European Journal of Haematology, 2011, v. 87, n. 4, p. 338, doi. 10.1111/j.1600-0609.2011.01660.x

By:

Porter, John B.;
Lin, Kai-Hsin;
Beris, Photis;
Forni, Gian Luca;
Taher, Ali;
Habr, Dany;
Domokos, Gabor;
Roubert, Bernard;
Thein, Swee Lay

Publication type:

Article

Relation of myocardial T2* to right ventricular function in thalassaemia major.

Published in:

European Heart Journal, 2010, v. 31, n. 13, p. 1648, doi. 10.1093/eurheartj/ehq106

By:

Alpendurada, Francisco;
Carpenter, John-Paul;
Deac, Monica;
Kirk, Paul;
Walker, J. Malcolm;
Porter, John B.;
Banya, Winston;
He, Taigang;
Smith, Gill C.;
Pennell, Dudley J.

Publication type:

Article

Challenges of adherence and persistence with iron chelation therapy.

Published in:

2011

By:

Porter, John;
Evangeli, Michael;
El-Beshlawy, Amal;
Porter, John B

Publication type:

journal article

Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia.

Published in:

American Journal of Hematology, 2024, v. 99, n. 2, p. 182, doi. 10.1002/ajh.27102

By:

Garbowski, Maciej W.;
Ugidos, Manuel;
Risueño, Alberto;
Shetty, Jeevan K.;
Schwickart, Martin;
Hermine, Olivier;
Porter, John B.;
Thakurta, Anjan;
Vodala, Sadanand

Publication type:

Article

SLN124, a GalNAc conjugated 19‐mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers.

Published in:

American Journal of Hematology, 2023, v. 98, n. 9, p. 1425, doi. 10.1002/ajh.27015

By:

Porter, John B.;
Scrimgeour, Alison;
Martinez, Alberto;
James, Leo;
Aleku, Manuela;
Wilson, Rosamund;
Muckenthaler, Martina;
Boyce, Malcolm;
Wilkes, Denise;
Schaeper, Ute;
Campion, Giles V.

Publication type:

Article

Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency.

Published in:

American Journal of Hematology, 2023, v. 98, n. 3, p. E57, doi. 10.1002/ajh.26830

By:

Al‐Samkari, Hanny;
Grace, Rachael F.;
Glenthøj, Andreas;
Andres, Oliver;
Barcellini, Wilma;
Galactéros, Frédéric;
Kuo, Kevin H. M.;
Layton, D. Mark;
Morado Arias, Marta;
Viprakasit, Vip;
Dong, Yan;
Tai, Feng;
Hawkins, Peter;
Gheuens, Sarah;
Morales‐Arias, Jaime;
Gilroy, Keely S.;
Porter, John B.;
van Beers, Eduard J.

Publication type:

Article

The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration.

Published in:

American Journal of Hematology, 2023, v. 98, n. 3, p. 533, doi. 10.1002/ajh.26819

By:

Garbowski, Maciej W.;
Cabantchik, Ioav;
Hershko, Chaim;
Hider, Robert;
Porter, John B.

Publication type:

Article

Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron–nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation".

Published in:

American Journal of Hematology, 2022, v. 97, n. 2, p. E58, doi. 10.1002/ajh.26419

By:

Garbowski, Maciej W.;
Porter, John B.;
Hider, Robert

Publication type:

Article

Influence of patient‐reported outcomes on the treatment effect of deferasirox film‐coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.

Published in:

American Journal of Hematology, 2019, v. 94, n. 4, p. E96, doi. 10.1002/ajh.25408

By:

Taher, Ali T.;
Origa, Raffaella;
Perrotta, Silverio;
Kouraklis, Alexandra;
Belhoul, Khawla;
Huang, Vicky;
Han, Jackie;
Bruederle, Andreas;
Bobbili, Priyanka;
Duh, Mei Sheng;
Porter, John B.

Publication type:

Article

Predicting serum ferritin levels in patients with iron overload treated with the film‐coated tablet of deferasirox during the ECLIPSE study.

Published in:

American Journal of Hematology, 2019, v. 94, n. 1, p. E15, doi. 10.1002/ajh.25322

By:

Taher, Ali T.;
Weber, Sebastian;
Han, Jackie;
Bruederle, Andreas;
Porter, John B.

Publication type:

Article

New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 5, p. 420, doi. 10.1002/ajh.24668

By:

Taher, Ali T.;
Origa, Raffaella;
Perrotta, Silverio;
Kourakli, Alexandra;
Ruffo, Giovan Battista;
Kattamis, Antonis;
Goh, Ai-Sim;
Cortoos, Annelore;
Huang, Vicky;
Weill, Marine;
Merino Herranz, Raquel;
Porter, John B.

Publication type:

Article

Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.

Published in:

American Journal of Hematology, 2015, v. 90, n. 2, p. 91, doi. 10.1002/ajh.23876

By:

Pennell, Dudley J.;
Porter, John B.;
Piga, Antonio;
Lai, Yong-Rong;
El-Beshlawy, Amal;
Elalfy, Mohsen;
Yesilipek, Akif;
Kilinç, Yurdanur;
Habr, Dany;
Musallam, Khaled M.;
Shen, Junwu;
Aydinok, Yesim

Publication type:

Article

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients.

Published in:

American Journal of Hematology, 2013, v. 88, n. 6, p. 503, doi. 10.1002/ajh.23445

By:

Taher, Ali T.;
Porter, John B.;
Viprakasit, Vip;
Kattamis, Antonis;
Chuncharunee, Suporn;
Sutcharitchan, Pranee;
Siritanaratkul, Noppadol;
Galanello, Renzo;
Karakas, Zeynep;
Lawniczek, Tomasz;
Habr, Dany;
Ros, Jacqueline;
Zhang, Yiyun;
Cappellini, M. Domenica

Publication type:

Article

Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort.

Published in:

American Journal of Hematology, 2010, v. 85, n. 10, p. 802, doi. 10.1002/ajh.21826

By:

Mednick, Lauren;
Yu, Shuli;
Trachtenberg, Felicia;
Xu, Yan;
Kleinert, Dorothy A.;
Giardina, Patricia J.;
Kwiatkowski, Janet L.;
Foote, Dru;
Thayalasuthan, Vivekanandan;
Porter, John B.;
Thompson, Alexis A.;
Schilling, Leann;
Quinn, Charles T.;
Neufeld, Ellis J.;
Yamashita, Robert

Publication type:

Article

Concepts and goals in the management of transfusional iron overload.

Published in:

American Journal of Hematology, 2007, v. 82, p. 1136, doi. 10.1002/ajh.21100

By:

Porter, John B.

Publication type:

Article

Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice.

Published in:

Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.1053060

By:

Settakorn, Kornvipa;
Kongkarnka, Sarawut;
Chompupoung, Anchan;
Svasti, Saovaros;
Fucharoen, Suthat;
Porter, John B.;
Srichairatanakool, Somdet;
Koonyosying, Pimpisid

Publication type:

Article

Extracts of Thai Perilla frutescens nutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells.

Published in:

Bioscience Reports, 2020, v. 40, n. 5, p. 1, doi. 10.1042/BSR20192110

By:

Narisara Paradee;
Niramon Utama-ang;
Chairat Uthaipibull;
Porter, John B.;
Garbowski, Maciej W.;
Somdet Srichairatanakool

Publication type:

Article

One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.

Published in:

2017

By:

Inati, Adlette;
Kahale, Mario;
Sbeiti, Nada;
Cappellini, Maria Domenica;
Taher, Ali T.;
Koussa, Suzanne;
Nasr, Therese A.;
Musallam, Khaled M.;
Abbas, Hussein A.;
Porter, John B.

Publication type:

journal article

TIF Guidelines for the Management of Transfusion‐Dependent β‐Thalassemia.

Published in:

HemaSphere, 2025, v. 9, n. 3, p. 1, doi. 10.1002/hem3.70095

By:

Musallam, Khaled M.;
Cappellini, Maria Domenica;
Porter, John B.;
Farmakis, Dimitrios;
Eleftheriou, Androulla;
Angastiniotis, Michael;
Taher, Ali T.

Publication type:

Article

P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972868.69615.42

By:

van Beers, Eduard;
Al‐Samkari, Hanny;
Grace, Rachael F.;
Barcellini, Wilma;
Glenthøj, Andreas;
Beynon, Vanessa;
Wind‐Rotolo, Megan;
Xu, Rengyi;
Dibacco, Melissa;
Patel, Parija;
Porter, John B.;
Kuo, Kevin H.M.

Publication type:

Article

S273: LONG‐TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON‐TRANSFUSION‐DEPENDENT ΒETA‐THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000968004.45673.ef

By:

Taher, Ali T.;
Viprakasit, Vip;
Domenica Cappellini, Maria;
Giulio Piga, Antonio;
Porter, John B.;
Coates, Thomas D.;
Musallam, Khaled M.;
Luca Forni, Gian;
Shetty, Jeevan K.;
Bosilkovska Weisskopf, Marija;
Wei, Richard;
Kuo, Wen‐Ling;
Kattamis, Antonis

Publication type:

Article

P1493: DIAGNOSTIC ACCURACY OF AN AUTOMATED MAGNETIC RESONANCE IMAGE ANALYSIS SYSTEM FOR THE RAPID EVALUATION OF LIVER IRON CONCENTRATION IN PATIENTS WITH HFE RELATED HEMOCHROMATOSIS.

Published in:

2023

By:

Porter, John B.;
Eleftheriou, Perla;
Drasar, Emma;
Mullally, Ryan;
Suri, Deepak;
Le, Kim;
Moon, James;
Muth, Stephanie;
St Pierre, Tim

Publication type:

Abstract

Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm.

Published in:

2022

By:

Musallam, Khaled M.;
Taher, Ali T.;
Cappellini, Maria Domenica;
Hermine, Olivier;
Kuo, Kevin H. M.;
Sheth, Sujit;
Viprakasit, Vip;
Porter, John B.

Publication type:

Editorial

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.

Published in:

Drug Design, Development & Therapy, 2016, v. 10, p. 4073, doi. 10.2147/DDDT.S117080

By:

Taher, Ali T.;
Porter, John B.;
Kattamis, Antonis;
Viprakasit, Vip;
Cappellini, M. Domenica

Publication type:

Article

High index of suspicion for early diagnosis of alendronate-induced stage zero osteonecrosis of jaw in thalassaemia major.

Published in:

British Journal of Haematology, 2014, v. 166, n. 2, p. 292, doi. 10.1111/bjh.12833

By:

Chatterjee, Ratna;
Bajoria, Rekha;
Shah, Farrukh T.;
Porter, John B.;
Fedele, Stefano

Publication type:

Article

Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome.

Published in:

British Journal of Haematology, 2012, v. 159, n. 4, p. 462, doi. 10.1111/bjh.12048

By:

Chatterjee, Ratna;
Shah, Farrukh T.;
Davis, Bernard A.;
Byers, Margaret;
Sooranna, Dev;
Bajoria, Rekha;
Pringle, Jean;
Porter, John B.

Publication type:

Article

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload.

Published in:

British Journal of Haematology, 2009, v. 147, n. 5, p. 752, doi. 10.1111/j.1365-2141.2009.07908.x

By:

Taher, Ali;
Cappellini, Maria D.;
Vichinsky, Elliott;
Galanello, Renzo;
Piga, Antonio;
Lawniczek, Tomasz;
Clark, Joan;
Habr, Dany;
Porter, John B.

Publication type:

Article

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.

Published in:

British Journal of Haematology, 2004, v. 127, n. 3, p. 348, doi. 10.1111/j.1365-2141.2004.05202.x

By:

Anderson, Lisa J.;
Westwood, Mark A.;
Holden, Sally;
Davis, Bernard;
Prescott, Emma;
Wonke, Beatrix;
Porter, John B.;
Malcolm Walker, J.;
Pennell, Dudley J.

Publication type:

Article

Review.

Published in:

British Journal of Haematology, 2001, v. 115, n. 2, p. 239

By:

Porter, John B.

Publication type:

Article

The metabolites of nitric oxide in sickle-cell disease.

Published in:

British Journal of Haematology, 1995, v. 91, n. 4, p. 834, doi. 10.1111/j.1365-2141.1995.tb05397.x

By:

Rees, David C.;
Cervi, Paul;
Grimwade, David;
O'Driscoll, Aisling;
Hamilton, Malcolm;
Parker, Norman E.;
Porter, John B.

Publication type:

Article

Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.

Published in:

British Journal of Haematology, 1993, v. 85, n. 2, p. 393, doi. 10.1111/j.1365-2141.1993.tb03184.x

By:

Hoyes, Katherine P.;
Porter, John B.

Publication type:

Article

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage.

Published in:

British Journal of Haematology, 1989, v. 73, n. 3, p. 403, doi. 10.1111/j.1365-2141.1989.tb07761.x

By:

Porter, John B.;
Jaswon, Mervyn S.;
Huehns, Ernst R.;
East, Charles A.;
Hazell, Jonathan W. P.

Publication type:

Article

Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias.

Published in:

2018

By:

Taher, Ali T.;
Origa, Raffaella;
Perrotta, Silverio;
Kouraklis, Alexandra;
Ruffo, Giovan Battista;
Kattamis, Antonis;
Goh, Ai-Sim;
Huang, Vicky;
Zia, Aiesha;
Herranz, Raquel Merino;
Porter, John B.

Publication type:

journal article

Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias.

Published in:

Blood Transfusion (17232007), 2013, v. 11, n. 1, p. 108, doi. 10.2450/2012.0012-12

By:

Viprakasit, Vip;
Gattermann, Norbert;
Jong Wook Lee;
Porter, John B.;
Taher, Ali T.;
Habr, Dany;
Martin, Nicolas;
Domokos, Gabor;
Cappellini, Maria Domenica

Publication type:

Article

Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.

Published in:

Transfusion, 2008, v. 48, n. 9, p. 1971, doi. 10.1111/j.1537-2995.2008.01775.x

By:

Fung, Ellen B.;
Harmatz, Paul R.;
Milet, Meredith;
Balasa, Vinod;
Ballas, Samir K.;
Casella, James F.;
Hilliard, Lee;
Kutlar, Abdullah;
McClain, Kenneth L.;
Olivieri, Nancy F.;
Porter, John B.;
Vichinsky, Elliott P.

Publication type:

Article

Deferasirox—current knowledge and future challenges.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 87, doi. 10.1111/j.1749-6632.2010.05582.x

By:

Porter, John B.

Publication type:

Article

Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia.

Published in:

Hemoglobin, 2018, v. 42, n. 1, p. 30, doi. 10.1080/03630269.2018.1433686

By:

Vosper, Jane;
Evangeli, Michael;
Porter, John B.;
Shah, Farrukh

Publication type:

Article

Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [ HBA2 : c.269A>T (or HBA1 )] and α -Thalassemia: A Clinical Update.

Published in:

2016

By:

Oliveira, Amelia;
Warcel, Dana;
Huntley, Nancy;
Eleftheriou, Perla;
Porter, John B.

Publication type:

Case Study

Secondary Erythrocytosis Due to Compound Homozygosity, but not Compound Heterozygosity, for Hb Luton and α-Thalassemia: A Family Study.

Published in:

Hemoglobin, 2012, v. 36, n. 1, p. 7, doi. 10.3109/03630269.2011.641134

By:

El-Sharkawi, Dima;
Fisher, Chris;
Khambadkone, Sachin;
Stephens, Adrian D.;
Porter, John B.

Publication type:

Article

Which Psychosocial Factors are Related to Chelation Adherence in Thalassemia? A Systematic Review.

Published in:

Hemoglobin, 2010, v. 34, n. 3, p. 305, doi. 10.3109/03630269.2010.485080

By:

Evangeli, Michael;
Mughal, Kulsoom;
Porter, John B.

Publication type:

Article

Pathophysiology of Transfusional Iron Overload: Contrasting Patterns in Thalassemia Major and Sickle Cell Disease.

Published in:

Hemoglobin, 2009, v. 33, p. S37, doi. 10.3109/03630260903346627

By:

Porter, John B.

Publication type:

Article

Deferasirox: An Update.

Published in:

Hemoglobin, 2009, v. 33, p. S70, doi. 10.3109/03630260903347146

By:

Porter, John B.

Publication type:

Article

Ethical Issues and Risk/Benefit Assessment of Iron Chelation Therapy: Advances with Deferiprone/deferoxamine Combinations and Concerns about the Safety, Efficacy and Costs of Deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.].

Published in:

Hemoglobin, 2008, v. 32, n. 6, p. 601, doi. 10.1080/03630260802342008

By:

Porter, John B.;
Taher, Ali T.;
Cappellini, Maria D.;
Vichinsky, Elliott P.

Publication type:

Article

Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice.

Published in:

Asian Pacific Journal of Tropical Medicine, 2014, v. 7, p. S155, doi. 10.1016/S1995-7645(14)60223-6

By:

Chansiw, Nittaya;
Pangjit, Kanjana;
Phisalaphong, Chada;
Porter, John B.;
Evans, Patricia;
Fucharoen, Suthat;
Srichairatanakool, Somdet

Publication type:

Article

Cross-Talk between Available Guidelines for the Management of Patients with Beta-Thalassemia Major.

Published in:

Acta Haematologica, 2013, v. 130, n. 2, p. 64, doi. 10.1159/000345734

By:

Musallam, Khaled M.;
angastiniotis, Michael;
Eleftheriou, androulla;
Porter, John B.

Publication type:

Article

Evaluation of New Iron Chelators for Clinical Use.

Published in:

Acta Haematologica, 1996, v. 95, n. 1, p. 13, doi. 10.1159/000203852

By:

Porter, John B.

Publication type:

Article

Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.

Published in:

British Journal of Haematology, 2022, v. 196, n. 2, p. 336, doi. 10.1111/bjh.17839

By:

Shah, Farrukh T.;
Porter, John B.;
Sadasivam, Nandini;
Kaya, Banu;
Moon, James C.;
Velangi, Mark;
Ako, Emmanuel;
Pancham, Shivan

Publication type:

Article

Iron Through the Prism of Haematology.

Published in:

British Journal of Haematology, 2020, v. 191, n. 4, p. 587, doi. 10.1111/bjh.17164

By:

Porter, John B.

Publication type:

Article

Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.

Published in:

British Journal of Haematology, 2017, v. 176, n. 2, p. 179, doi. 10.1111/bjh.14346

By:

Davis, Bernard A.;
Allard, Shubha;
Qureshi, Amrana;
Porter, John B.;
Pancham, Shivan;
Win, Nay;
Cho, Gavin;
Ryan, Kate

Publication type:

Article

Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.

Published in:

British Journal of Haematology, 2017, v. 176, n. 2, p. 288, doi. 10.1111/bjh.14373

By:

Porter, John B.;
Cappellini, Maria Domenica;
Kattamis, Antonis;
Viprakasit, Vip;
Musallam, Khaled M.;
Zhu, Zewen;
Taher, Ali T.

Publication type:

Article